Ann Arbor Stage IB Hodgkin Lymphoma
Oncology
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
2 drugs in development·1 company·2 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Ann Arbor Stage IB Hodgkin Lymphoma?
BioSniper tracks 2 drugs in development for Ann Arbor Stage IB Hodgkin Lymphoma across 1 company.
How many clinical trials target Ann Arbor Stage IB Hodgkin Lymphoma?
There are 2 clinical trials targeting Ann Arbor Stage IB Hodgkin Lymphoma tracked by BioSniper.
What is the prevalence of Ann Arbor Stage IB Hodgkin Lymphoma?
The estimated prevalence of Ann Arbor Stage IB Hodgkin Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Ann Arbor Stage IB Hodgkin Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis